Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of oral enteric-coated insulin capsules plus oral antidiabetic drugs in poorly controlled type 2 diabetes
CTR20192051Phase 3Active
- Sponsor
- Fosse Bio-Engineering Development Limited
- Start
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Fosse Bio-Engineering Development Limited. Started Oct 2019; status: active.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20192051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192051.